These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 101472)

  • 21. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mode of action and indication for appetite depressants in the treatment of obesity].
    Stauffacher W
    Schweiz Med Wochenschr; 1975 Apr; 105(15):461-6. PubMed ID: 1124373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Kuo MH; Kuo DY
    Arch Toxicol; 2013 Mar; 87(3):469-79. PubMed ID: 23052195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic self-stimulation and stimulation escape in relation to feeding and mating.
    Hoebel BG
    Fed Proc; 1979 Oct; 38(11):2454-61. PubMed ID: 385351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Judicious use of anorectics].
    Laurent-Jaccard A
    Schweiz Rundsch Med Prax; 1991 Feb; 80(6):116-7. PubMed ID: 2003174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of anorectic drugs (Amphetamine), amfepramone and UP 507-O4) on two models of obesity in animals [proceedings].
    Dumeur G; Hüe B; Lwoff JM; Mouries MA; Tremblay D
    Br J Pharmacol; 1976 Nov; 58(3):437P. PubMed ID: 990622
    [No Abstract]   [Full Text] [Related]  

  • 27. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
    Rodgers RJ; Holch P; Tallett AJ
    Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight.
    Engeli S
    Handb Exp Pharmacol; 2012; (209):357-81. PubMed ID: 22249824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of protein kinase Calpha isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression.
    Kuo DY; Yang SF; Chu SC; Chen CH; Hsieh YS
    J Neurochem; 2009 Mar; 108(6):1495-506. PubMed ID: 19183253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies with phenylpropanolamine: a metaanalysis.
    Greenway FL
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):203S-205S. PubMed ID: 1530830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and neurochemical evaluation of phenylpropanolamine.
    Woolverton WL; Johanson CE; de la Garza R; Ellis S; Seiden LS; Schuster CR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):926-30. PubMed ID: 3712285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current status of antiobesity drugs.
    Galloway SM; Farquhar DL; Munro JF
    Postgrad Med J; 1984; 60 Suppl 3():19-26. PubMed ID: 6393107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salbutamol, d-amphetamine and d-fenfluramine reduce sucrose intake in freely fed rats by acting on different neurochemical mechanisms.
    Borsini F; Bendotti C; Samanin R
    Int J Obes; 1985; 9(4):277-83. PubMed ID: 4066115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Eur J Neurosci; 2005 Aug; 22(3):715-23. PubMed ID: 16101753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD; Yuan J; Ricaurte GA
    Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of tolerance to drugs that suppress food intake.
    Fernstrom JD; Choi S
    Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What to tell patients about weight-loss methods. 2. Drugs.
    Friedman RB; Kindy P; Reinke JA
    Postgrad Med; 1982 Oct; 72(4):85-8. PubMed ID: 7122365
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of the anorectic drug, phenylpropanolamine, on blood glucose in rats.
    Resnick SI; Hernandez L; Chen J; Hoebel BG
    Pharmacology; 1978; 17(3):157-62. PubMed ID: 704658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurochemical mechanism of action of anorectic drugs.
    Samanin R; Garattini S
    Pharmacol Toxicol; 1993 Aug; 73(2):63-8. PubMed ID: 7902561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs, appetite and obesity: a personal odyssey.
    Silverstone T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 2():S49-52. PubMed ID: 1335991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.